Centrexion Therapeutics Corp Watch

from S-1/A 5 pages Centrexion Therapeutics Corporation September 19th, 2018

from S-1/A 5 pages Material contract

from S-1/A 68 pages Collaboration and License Agreement Between Eli Lilly and Company and Centrexion Therapeutics Corporation May 24, 2019 Certain Information in This Exhibit Marked as [***] Has Been Excluded Pursuant to Regulation S-K, Item 601(b)(10). Such Excluded Information Is Not Material and Would Be Competitively Harmful if Publicly Disclosed

from S-1/A 6 pages Material contract

from S-1/A 48 pages Centrexion Corporation 2013 Equity Incentive Plan Adopted as of November 19, 2013 Centrexion Corporation 2013 Equity Incentive Plan

from S-1/A 5 pages Amendment #1 to Patent Assignment and Licensing Agreement

from S-1/A 22 pages October 8, 2013 by Email Jeffrey Kindler [***] [***] Re: Executive Employment Agreement Dear Jeff: This Letter Agreement (The “Agreement”) Confirms the Terms and Conditions of Your Employment With Centrexion Corporation (The “Company”)

from S-1/A 5 pages Amendment #1 to Patent Assignment and Licensing Agreement

from S-1/A 46 pages List of Exhibits

from S-1/A 15 pages Centrexion Therapeutics Corporation Indemnification Agreement

from S-1/A 5 pages Centrexion Therapeutics Corporation Non-Employee Director Compensation Program

from S-1/A 14 pages Centrexion Therapeutics Corporation 2018 Employee Stock Purchase Plan

from S-1/A 32 pages Centrexion Therapeutics Corporation 2018 Incentive Award Plan

from S-1 5 pages Material contract

from S-1 5 pages Promptly Following the Closing of the Acquisition, and Subject to Your Continued Employment With the Company, You Will Be Granted an Option to Purchase 750,000 Shares of the Company’s Common Stock, Which Option Will Be Subject to Monthly Vesting Over a Three-Year Period Based on Continued Employment. to the Maximum Extent Possible, the Option Will Be Granted as an “Incentive Stock Option” Under Section 422 of the Internal Revenue Code of 1986, as Amended (The “Code”). the Option Will Be Granted in Accordance With and Pursuant to the Company’s Equity Incentive Plan and Applicable Form of Award Agreement. the Terms of the Option Will Be No Less Favorable to You in Any Respect as Any Option Granted to Any Other Senior Executive of the Company

from S-1 19 pages October 8, 2013 by Email Jeffrey Kindler [***] [***] Re: Executive Employment Agreement Dear Jeff: This Letter Agreement (The “Agreement”) Confirms the Terms and Conditions of Your Employment With Centrexion Corporation (The “Company”)

from S-1 61 pages License Agreement

from S-1 5 pages Amendment #1 to Patent Assignment and Licensing Agreement

from S-1 46 pages List of Exhibits

from S-1 62 pages 200 State Street Boston, Massachusetts Office Lease Agreement Between Gll 200 State Street, L.P., a Delaware Limited Partnership (“Landlord”) and Centrexion Therapeutics Corporation a Delaware Corporation